David Lim

Health Reporter at POLITICO

washington, district of columbia, united states

Publications:

cclubsnap.com

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

About

A reporter covering the Food and Drug Administration, with an emphasis on medical technology. Mixing a background in economics and journalism, I focus on communicating the impact of policy, politics and business.

Featured Articles

Comment on Genting Malaysia Delisting - What should retail shareholders do? by David Lim

Genting Malaysia Berhad (KLSE: GENM) used to be the stock darling of the Malaysia stock market. While the stock once hit a high of RM6 per share, it is currently languishing at a low of RM2.34. Almost every Malaysians have had a childhood memory tied to G... See more

drwealth.com•David Lim•Nov 9, 2025

Politico Pro: Drugmakers lay out sparse response to Trump drug pricing demands | Congressman Lloyd Doggett

Politico Pro: Drugmakers lay out sparse response to Trump drug pricing demands The largest drug lobby on Monday rolled out a slate of commitments including U.S. manufacturing investments and a direct purchase website, but fell short of President Donald Tr... See more

house.gov•David Lim•Sep 29, 2025

Bylined Articles

HARO Queries

Portfolio

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

LinkedIn X

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

1K +

Articles10

Last Articlea month ago

Stats

Education

Bachelor Of Science, Economics, Journalism at American UniversityGraduated: 2016

Economics at Dis - Study AbroadGraduated: 2015

Education

David Lim

Is this you?

About

Featured Articles

Comment on Genting Malaysia Delisting - What should retail shareholders do? by David Lim

Politico Pro: Drugmakers lay out sparse response to Trump drug pricing demands | Congressman Lloyd Doggett

Is this you?

Social Media

Education

Connect with journalists.

Connect with journalists.

Featured Articles

Comment on Genting Malaysia Delisting - What should retail shareholders do? by David Lim

Politico Pro: Drugmakers lay out sparse response to Trump drug pricing demands | Congressman Lloyd Doggett

Social Media

Education